Gene · 8529
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences. | Sci Rep | 2024 | 39354004 | PubTator, text mining | PubMed |
| Accuracy of an internationally validated genetic-guided warfarin dosing algorithm compared to a clinical algorithm in an Arab population. | Curr Probl Cardiol | 2024 | 39317306 | PubTator, text mining | PubMed |
| Patterns of pharmacogenetic variation in nine biogeographic groups. | Clin Transl Sci | 2024 | 39206687 | PubTator, text mining | PubMed |
| A Pharmacogenetic Panel-Based Prediction of the Clinical Outcomes in Elderly Patients with Coronary Artery Disease. | Pharmaceutics | 2024 | 39204424 | PubTator, text mining | PubMed |
| The Role of the Pharmacist in a Patient's Care for Individuals Undergoing Anticoagulant Therapy: A Case Report. | Life (Basel) | 2024 | 39202728 | PubTator, text mining | PubMed |
| 11-Hydroxyeicosatetraenoics induces cellular hypertrophy in an enantioselective manner. | Front Pharmacol | 2024 | 39188949 | PubTator, text mining | PubMed |
| Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function. | Pharmazie | 2024 | 39152554 | PubTator, text mining | PubMed |
| PharmVar GeneFocus: CYP4F2. | Clin Pharmacol Ther | 2024 | 39135485 | PubTator, text mining | PubMed |
| Correction to "Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals". | Clin Pharmacol Ther | 2024 | 39039894 | PubTator, text mining | PubMed |
| How nurses face a new era of genomics medicine and precision health: Oncology nurse clinicians' perspective. | Asia Pac J Oncol Nurs | 2024 | 39006319 | PubTator, text mining | PubMed |
| Identification of early coagulation changes associated with survival outcomes post severe burns from multiple perspectives. | Sci Rep | 2024 | 38714778 | PubTator, text mining | PubMed |
| Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort. | Pharmacotherapy | 2024 | 38686648 | PubTator, text mining | PubMed |
| Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants. | Genes (Basel) | 2024 | 38674455 | PubTator, text mining | PubMed |
| Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer. | Biochem Biophys Rep | 2024 | 38646426 | PubTator, text mining | PubMed |
| Differential Tissue Abundance of Membrane-Bound Drug Metabolizing Enzymes and Transporter Proteins by Global Proteomics. | Drug Metab Dispos | 2024 | 38641346 | PubTator, text mining | PubMed |
| Cytochrome P450 Family 4F2 and 4F11 Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation Activity. | ACS Pharmacol Transl Sci | 2024 | 38481683 | PubTator, text mining | PubMed |
| Cytochrome P450 genes expression in human prostate cancer. | Mol Genet Metab Rep | 2024 | 38469085 | PubTator, text mining | PubMed |
| Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients. | Nefrologia (Engl Ed) | 2024 | 38448299 | PubTator, text mining | PubMed |
| Being precise with anticoagulation to reduce adverse drug reactions: are we there yet? | Pharmacogenomics J | 2024 | 38443337 | PubTator, text mining | PubMed |
| Antioxidant Genes Variants and Their Association with Sperm DNA Fragmentation. | Biochem Genet | 2024 | 38294591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8529/papers?page=4